A Dose Escalation Study of Tenofovir Alafenamide in Treatment-Naive Patients
Condition(s):HIV InfectionsLast Updated:January 15, 2014Completed
Hide Studies Not Open or Pending
Condition(s):HIV InfectionsLast Updated:January 15, 2014Completed
Condition(s):HIV InfectionsLast Updated:October 25, 2021Completed
Condition(s):HIV I Infection; Cardiovascular Risk Factor; Lipid Metabolism DisordersLast Updated:March 12, 2024Recruiting
Condition(s):Chronic Hepatitis bLast Updated:December 22, 2020Recruiting
Condition(s):B-cell Lymphoma; HBVLast Updated:September 4, 2020Recruiting
Condition(s):Healthy Adult FemalesLast Updated:June 19, 2014Completed
Condition(s):Hepatitis B Virus (HBV)Last Updated:September 1, 2016Completed
Condition(s):Chronic Hepatitis BLast Updated:February 12, 2019Completed
Condition(s):HIV InfectionsLast Updated:November 1, 2021Withdrawn
Condition(s):Chronic Hepatitis BLast Updated:December 13, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.